HPV infection
Conditions
Interventions
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: 1. aged from 18 to 70 years female; 2. Clinically diagnosed as HPV positive patients (including primary infection and persistent infection), or pathologically diagnosed as cervical low-grade intraepithelial neoplasia (CIN1) or vaginal low-grade intraepithelial neoplasia (VAIN1) with HPV infection.
Exclusion criteria
Exclusion criteria: 1. Allergic to any component in the product; 2. Cervical cancer or high-grade cervical/vaginal intraepithelial neoplasia has been confirmed by pathology; 3. Those who have taken measures to treat HPV infection in the past 3 months; 4. Long-term use of corticosteroids or immunosuppressants; 5. Pregnant or nursing women, or those who have a family planning in the near future; 6. The researcher considers that the study is not suitable for patients for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HPV-DNA; | — |
Countries
China
Contacts
Nanjing University of Chinese Medicine